A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation - PubMed (original) (raw)

A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation

W P Hausdorff et al. Proc Natl Acad Sci U S A. 1991.

Abstract

Plasma membrane receptors that couple to guanine nucleotide-binding regulatory proteins (G proteins) undergo a variety of rapid (minutes) and longer term (hours) regulatory processes induced by ligands. For the beta 2-adrenergic receptor (beta 2AR), the rapid processes include functional desensitization, mediated by phosphorylation of the receptor by the cAMP-dependent protein kinase and the beta-adrenergic receptor kinase, as well as a loss of hydrophilic ligand binding proposed to represent sequestration of receptors into a cellular compartment distinct from the plasma membrane. The slower processes include beta 2AR down-regulation (i.e., a decrease in the total cellular complement of receptors). It is not yet known whether beta 2AR phosphorylation and/or sequestration are prerequisites for down-regulation of the receptor. Like other G protein-coupled receptors, the beta 2AR molecule spans the plasma membrane seven times, and the cytoplasmic carboxyl-terminal domain has been proposed to contain molecular determinants for each of these regulatory processes. We replaced four serine and threonine residues located within a 10-amino acid segment of this domain of beta 2AR and thereby prevented agonist-promoted phosphorylation, sequestration, and rapid desensitization of the adenylyl cyclase response. In contrast, these mutations did not affect functional coupling to the stimulatory G protein Gs or long-term down-regulation. These findings thus define a small, hitherto unappreciated region of the receptor molecule that may selectively subserve its rapid regulation. In addition, with the demonstration that beta 2AR does not have to be phosphorylated or sequestered in order to enter the down-regulation pathway, the results suggest that the classical receptor endocytosis model may not be appropriate for beta 2AR regulation.

PubMed Disclaimer

Cited by

From the H(2) receptor gene to reclassification of the H(2) receptor antagonists.
Alewijnse AE. Alewijnse AE. Inflammopharmacology. 1998;6(2):179-92. doi: 10.1007/s10787-998-0033-1. Inflammopharmacology. 1998. PMID: 17694373
A common intracellular allosteric binding site for antagonists of the CXCR2 receptor.
Salchow K, Bond ME, Evans SC, Press NJ, Charlton SJ, Hunt PA, Bradley ME. Salchow K, et al. Br J Pharmacol. 2010 Apr;159(7):1429-39. doi: 10.1111/j.1476-5381.2009.00623.x. Epub 2010 Mar 3. Br J Pharmacol. 2010. PMID: 20233217 Free PMC article.
Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.
Liggett SB, Freedman NJ, Schwinn DA, Lefkowitz RJ. Liggett SB, et al. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3665-9. doi: 10.1073/pnas.90.8.3665. Proc Natl Acad Sci U S A. 1993. PMID: 8386380 Free PMC article.
Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.
Shenoy SK, Lefkowitz RJ. Shenoy SK, et al. Biochem J. 2003 Nov 1;375(Pt 3):503-15. doi: 10.1042/BJ20031076. Biochem J. 2003. PMID: 12959637 Free PMC article. Review.
Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization.
Trapaidze N, Keith DE, Cvejic S, Evans CJ, Devi LA. Trapaidze N, et al. J Biol Chem. 1996 Nov 15;271(46):29279-85. doi: 10.1074/jbc.271.46.29279. J Biol Chem. 1996. PMID: 8910588 Free PMC article.

References

1. Mol Pharmacol. 1991 Feb;39(2):192-8 - PubMed
1. J Mol Biol. 1978 Mar 25;120(1):97-120 - PubMed
1. J Biol Chem. 1989 Nov 25;264(33):19535-9 - PubMed
1. Mol Pharmacol. 1989 Jan;35(1):132-8 - PubMed
1. J Biol Chem. 1987 Oct 15;262(29):14282-8 - PubMed

A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation - PubMed (original) (raw)